[go: up one dir, main page]

GB201706816D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB201706816D0
GB201706816D0 GBGB1706816.4A GB201706816A GB201706816D0 GB 201706816 D0 GB201706816 D0 GB 201706816D0 GB 201706816 A GB201706816 A GB 201706816A GB 201706816 D0 GB201706816 D0 GB 201706816D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1706816.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeptio Pharmaceuticals Ltd
Original Assignee
Adeptio Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeptio Pharmaceuticals Ltd filed Critical Adeptio Pharmaceuticals Ltd
Priority to GBGB1706816.4A priority Critical patent/GB201706816D0/en
Publication of GB201706816D0 publication Critical patent/GB201706816D0/en
Priority to CN201880035584.2A priority patent/CN110678181A/en
Priority to CA3057543A priority patent/CA3057543A1/en
Priority to RU2019134341A priority patent/RU2771164C2/en
Priority to EP18718396.7A priority patent/EP3606529A1/en
Priority to PCT/EP2018/058069 priority patent/WO2018178233A1/en
Priority to US15/939,822 priority patent/US20180280374A1/en
Priority to JP2019553959A priority patent/JP2020512986A/en
Priority to AU2018242134A priority patent/AU2018242134B2/en
Priority to US16/151,730 priority patent/US20190111035A1/en
Priority to US17/648,057 priority patent/US20220211678A1/en
Priority to JP2022192807A priority patent/JP2023014308A/en
Priority to AU2023274090A priority patent/AU2023274090B2/en
Ceased legal-status Critical Current

Links

GBGB1706816.4A 2017-04-01 2017-04-28 Pharmaceutical compositions Ceased GB201706816D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1706816.4A GB201706816D0 (en) 2017-04-28 2017-04-28 Pharmaceutical compositions
AU2018242134A AU2018242134B2 (en) 2017-04-01 2018-03-29 (+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
US15/939,822 US20180280374A1 (en) 2017-04-01 2018-03-29 Pharmaceutical compositions
CA3057543A CA3057543A1 (en) 2017-04-01 2018-03-29 (+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
RU2019134341A RU2771164C2 (en) 2017-04-01 2018-03-29 (+)-alpha-dihydrotetrabenazine for use in treatment of motor disorder
EP18718396.7A EP3606529A1 (en) 2017-04-01 2018-03-29 (+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
PCT/EP2018/058069 WO2018178233A1 (en) 2017-04-01 2018-03-29 (+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
CN201880035584.2A CN110678181A (en) 2017-04-01 2018-03-29 Use of (+)-α-dihydrotetrabenazine in the treatment of dyskinesia
JP2019553959A JP2020512986A (en) 2017-04-01 2018-03-29 (+)-Α-Dihydrotetrabenazine for use in the treatment of movement disorders
US16/151,730 US20190111035A1 (en) 2017-04-01 2018-10-04 Pharmaceutical compositions
US17/648,057 US20220211678A1 (en) 2017-04-01 2022-01-14 Uses of (+)-a-dihydrotetrabenazine in methods of treating movement disorder
JP2022192807A JP2023014308A (en) 2017-04-01 2022-12-01 (+)-α-DIHYDROTETRABENAZINE FOR USE IN TREATMENT MOVEMENT DISORDER
AU2023274090A AU2023274090B2 (en) 2017-04-01 2023-11-28 (+)-Alpha-Dihydrotetrabenazine for use in the Treatment of a Movement Disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1706816.4A GB201706816D0 (en) 2017-04-28 2017-04-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB201706816D0 true GB201706816D0 (en) 2017-06-14

Family

ID=59010895

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1706816.4A Ceased GB201706816D0 (en) 2017-04-01 2017-04-28 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB201706816D0 (en)

Similar Documents

Publication Publication Date Title
IL271657A (en) Pharmaceutical compositions
IL269061A (en) Pharmaceutical composition comprising selexipag
IL271986A (en) Pharmaceutical composition
GB201608323D0 (en) Pharmaceutical compositions
IL271759A (en) Pharmaceutical compositions comprising entrectinib
GB201712159D0 (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
PL3583943T3 (en) Pharmaceutical composition
GB201705304D0 (en) Pharmaceutical compositions
SG11202001179YA (en) Pharmaceutical compositions
IL272419A (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
GB201705306D0 (en) Pharmaceutical compositions
GB201705305D0 (en) Pharmaceutical compositions
PL3646867T3 (en) Pharmaceutical composition
IL255510A (en) Pharmaceutical compositions
ZA202000014B (en) Pharmaceutical compositions
IL263999A (en) Pharmaceutical compositions
IL272044A (en) Pharmaceutical compositions
ZA201705782B (en) Pharmaceutical compositions
IL272428A (en) Pharmaceutical compositions
GB201715404D0 (en) Pharmaceutical compositions
GB201710114D0 (en) Pharmaceutical compositions
GB201706816D0 (en) Pharmaceutical compositions
GB201705302D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)